SCIE期刊Cancer Research and Treatment 2024/2025影响因子:4.194 (CANCER RES TREAT) (1598-2998). (ONCOLOGY)(肿瘤学)Science Citation

显示全部楼层 · 发表于 2025-3-27 04:10:51

Submitted on: 08 November 2011. Revised on: 07 March 2012. Accepted on: 24 April 2012. ___________________Cancer Research and Treatment---KOREAN CANCER ASSOCIATION

显示全部楼层 · 发表于 2025-3-27 06:42:16

Submitted on: 17 July 2013. Revised on: 23 October 2013. Accepted on: 10 December 2013. ___________________Cancer Research and Treatment---KOREAN CANCER ASSOCIATION

显示全部楼层 · 发表于 2025-3-27 09:58:15

Submitted on: 15 July 2015. Revised on: 07 November 2015. Accepted on: 03 January 2016. ___________________Cancer Research and Treatment---KOREAN CANCER ASSOCIATION

显示全部楼层 · 发表于 2025-3-27 17:37:32

显示全部楼层 · 发表于 2025-3-27 19:21:47

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 08:01
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

SCIE期刊Cancer Research and Treatment 2024/2025影响因子:4.194 (CANCER RES TREAT) (1598-2998). (ONCOLOGY)(肿瘤学)Science Citation

浏览过的版块